Clinical trial
Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants
NCT00131248 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00131248 |
|---|---|
| Title | Medical Treatment for Gastroesophageal Reflux Disease (GERD) in Preterm Infants |
| Official title | Cross-over Trial of Medical Treatment for GERD in Preterm Infants |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux |
| Intervention type | Drug |
| Interventions | Metaclopramide, Ranitidine, placebo |
| Enrollment | 18 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Aug 17, 2005 |
| Last update posted | Jan 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: